[
  {
    "ts": null,
    "headline": "How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Debate Growth And Margins",
    "summary": "Zimmer Biomet Holdings has seen its modeled fair value price target nudged from $102.96 to $102.65, signaling only a very small adjustment in the underlying valuation work. That slight trim comes as analysts remain split, with some highlighting potential upside if execution improves and others pointing to continued questions around growth and margins. As you read on, you will see how these differing views, and any further price target moves, can help you track the evolving story around the...",
    "url": "https://finnhub.io/api/news?id=cfffb5e5dd571ce3fbfb7dd638502794128bdb9b78a2cfe88a03cc7730b4cbb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772082552,
      "headline": "How The Zimmer Biomet (ZBH) Story Is Shifting As Analysts Debate Growth And Margins",
      "id": 139228753,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings has seen its modeled fair value price target nudged from $102.96 to $102.65, signaling only a very small adjustment in the underlying valuation work. That slight trim comes as analysts remain split, with some highlighting potential upside if execution improves and others pointing to continued questions around growth and margins. As you read on, you will see how these differing views, and any further price target moves, can help you track the evolving story around the...",
      "url": "https://finnhub.io/api/news?id=cfffb5e5dd571ce3fbfb7dd638502794128bdb9b78a2cfe88a03cc7730b4cbb1"
    }
  }
]